BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 169370)

  • 21. [Immunotherapy with BCG-CWS (cell-wall skeleton) in patients with primary lung cancer (author's transl)].
    Takano T; Morishita M; Yamamoto M; Yamagata K; Takada K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1977 Nov; 15(11):769-74. PubMed ID: 606901
    [No Abstract]   [Full Text] [Related]  

  • 22. Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer.
    McKneally MF; Maver C; Lininger L; Kausel HW; McIlduff JB; Older TM; Foster ED; Alley RD
    J Thorac Cardiovasc Surg; 1981 Apr; 81(4):485-92. PubMed ID: 7009993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic experience in lung cancer using BCG cell-wall skeleton--with special reference to cases of pleural effusion].
    Morishita M
    Kekkaku; 1977 Oct; 52(10):531-2. PubMed ID: 599772
    [No Abstract]   [Full Text] [Related]  

  • 25. Phase II trial of therapy with etoposide, 5-fluorouracil by continuous infusion, cisplatin, and simultaneous split-course radiation in stage III non-small cell bronchogenic carcinoma.
    Bonomi P; Rowland KM; Taylor SG; Pincus M; Reddy S; Lee MS; Faber LP; Warren W; Kittle CF
    NCI Monogr; 1988; (6):331-4. PubMed ID: 2832768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Results of combined treatment of small-cell bronchogenic carcinoma].
    Mostecký H; Melínová L; Zámecník J
    Vnitr Lek; 1980 Jan; 26(1):71-6. PubMed ID: 6243833
    [No Abstract]   [Full Text] [Related]  

  • 27. [BCG and levamisole in the treatment of advanced forms of lung cancer].
    Szafrański W
    Pneumonol Pol; 1980 Nov; 48(11):779-82. PubMed ID: 7255219
    [No Abstract]   [Full Text] [Related]  

  • 28. [What is safe in the therapy of non-small cell bronchial cancer?].
    Gropp C
    Internist (Berl); 1984 Dec; 25(12):747-51. PubMed ID: 6097563
    [No Abstract]   [Full Text] [Related]  

  • 29. Non-specific immunostimulation in bronchogenic cancer.
    Israel L
    Scand J Respir Dis Suppl; 1974; 89():95-105. PubMed ID: 4370224
    [No Abstract]   [Full Text] [Related]  

  • 30. Intralesional BCG immunotherapy of pulmonary tumors.
    Holmes EC; Ramming KP; Bein ME; Coulson WF; Callery CD
    J Thorac Cardiovasc Surg; 1979 Mar; 77(3):362-8. PubMed ID: 762979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoimmunotherapy of small cell bronchogenic carcinoma.
    Holoye PY; Samuels ML; Smith T; Sinkovics JG
    Cancer; 1978 Jul; 42(1):34-40. PubMed ID: 208755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Combination treatment of small cell bronchial carcinoma].
    Voss AC; Steinke B; Ostendorf P; Teller P; Gnann H
    Strahlentherapie; 1983 Jan; 159(1):18-21. PubMed ID: 6301108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnostic and therapeutic approach to lung neoplasms. Departmental experience at the Mestre Hospital].
    Nascimben O; Schiavon F; Pagan V; Giannico S; Agazia L; Turcato G; Polico R; Idi MB; Stea L; Conte G
    Radiol Med; 1988 May; 75(5):534-9. PubMed ID: 2453897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Negative results of a randomized therapeutic trial of nonspecific immunotherapy in primary, surgically-treated non-small cell bronchial cancer].
    Decroix G; Chastang C; Lebeau B; Fabre C; Lepage T; Rebishung JL; Babo P; Fichet D; Soubrane C; Asselain B
    Rev Mal Respir; 1984; 1(1):25-30. PubMed ID: 6379784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complications of intrapleural BCG in the treatment of operable non-small-cell bronchial carcinoma.
    Law MR; Lam WK; Studdy PR; Pugsley WB; Hodson ME
    Br J Dis Chest; 1982 Apr; 76(2):151-6. PubMed ID: 7093133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Combination chemotherapy for bronchogenic carcinoma based on cell type].
    Ohta M; Hara N; Ichikawa Y; Kanda T; Shima K; Hokama M
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):86-94. PubMed ID: 2417564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term survival in bronchogenic carcinoma.
    Ashor GL; Kern WH; Meyer BW; Lindesmith GG; Stiles QR; Tucker BL; Jones JC
    J Thorac Cardiovasc Surg; 1975 Oct; 70(4):581-9. PubMed ID: 170481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intralesional BCG injection of pulmonary neoplasms: radiographic findings.
    Fon GT; Bein ME; Holmes EC; Huberman RP
    AJR Am J Roentgenol; 1981 Aug; 137(2):269-75. PubMed ID: 6789633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The predictive value of purified protein derivative results on complications and prognosis in patients with bladder cancer treated with bacillus Calmette-Guerin.
    Bilen CY; Inci K; Erkan I; Ozen H
    J Urol; 2003 May; 169(5):1702-5. PubMed ID: 12686812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical biology of small cell carcinoma: relationship to surgical therapy.
    Mountain CF
    Semin Oncol; 1978 Sep; 5(3):272-9. PubMed ID: 211638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.